chr7-134178542-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144648.3(LRGUK):c.1147G>A(p.Val383Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144648.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRGUK | NM_144648.3 | c.1147G>A | p.Val383Ile | missense_variant | 10/20 | ENST00000285928.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRGUK | ENST00000285928.3 | c.1147G>A | p.Val383Ile | missense_variant | 10/20 | 1 | NM_144648.3 | P2 | |
LRGUK | ENST00000695542.2 | c.1147G>A | p.Val383Ile | missense_variant | 10/16 | A2 | |||
LRGUK | ENST00000645682.1 | c.1147G>A | p.Val383Ile | missense_variant | 10/16 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151950Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000837 AC: 21AN: 250776Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135538
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461178Hom.: 0 Cov.: 30 AF XY: 0.0000358 AC XY: 26AN XY: 726914
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151950Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74204
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2023 | The c.1147G>A (p.V383I) alteration is located in exon 10 (coding exon 10) of the LRGUK gene. This alteration results from a G to A substitution at nucleotide position 1147, causing the valine (V) at amino acid position 383 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at